Response to Comments: MolDX: Biomarkers in Cardiovascular Risk Assessment

Medicare covers the basic lipid panel (cholesterol, lipids, triglycerides) as a preventive cardiovascular screening every 5 years when ordered by a physician and under NCD 190.23 for evaluation or monitoring of atherosclerotic cardiovascular disease and lipid therapy. Non-lipid cardiovascular risk biomarker panels and non-lipid biomarkers (biochemical, hematologic, immunologic, genetic) for CV risk assessment are denied. Selected individual lipid biomarkers (hs-CRP, Lp(a), Lp-PLA2, LDL particles, Apo B) may be covered only when specifically ordered and the clinical reason is documented to guide diagnosis or therapy.

"Basic lipid panel (cholesterol, lipid and triglyceride levels) is covered as a Medicare Part B preventive cardiovascular screening when ordered by a physician."

Sign up to see full coverage criteria, indications, and limitations.